Close Menu

A Slippery Slope?

The Los Angeles Times' Booster Shots blog examines the National Collegiate Athletic Association's plan to "screen close to 167,000 college athletes for 'sickle cell trait,'" in light of a warning from two experts at the National Human Genome Research Institute that the program is "full of potential pitfalls." According to the LA Times, the NCAA program "aims to identify carriers of a single sickle-cell gene," as these individuals "have unusual vulnerabilitie

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.